Pinnacle Financial Partners »

Halozyme Therapeutics shares owned by Pinnacle Financial Partners

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Pinnacle Financial Partners from 13F filings

Historical chart of Pinnacle Financial Partners investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Pinnacle Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Pinnacle Financial Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.7M 84k 67.30